In conclusion, our study confirms the low prevalence of ROS1 rearrangements in Spanish NSCLC patients and shows a high prevalence of ROS1 CNAs that should be taken into account when assessed by FISH although do not present associated clinical implications. Here, ROS1 is linked to non-small cell lung carcinoma.